Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,351–6,375 of 27,380 studies, newest first · page 255 of 1096.

July 2024 25

  1. 2024-07-25
  2. 2024-07-25

    Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes

    ✓ Peer-reviewed TREM2 and immune genetics Neuron

    Key finding: Here, we report that microglia establish connections with neurons using tunneling nanotubes (TNTs) in both physiological and pathological conditions. +3 more findings

  3. 2024-07-24

    A genome-wide association meta-analysis of all-cause and vascular dementia

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: For ACD, novel loci identified were associated with energy transport (SEMA4D), neuronal excitability (ANO3), amyloid deposition in the brain (RBFOX1), and magnetic resonance imaging markers of small vessel disease (SVD; HBEGF). +4 more findings

  4. 2024-07-24

    Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders

    ✓ Peer-reviewed Risk factors JAMA Psychiatry

    Key finding: The analysis involved 4674 participants (2904 [62.13%] female and 1770 [37.87%] male; mean [SD] age, 41.51 [13.41] years). +4 more findings

  5. 2024-07-24

    Single-cell multiregion dissection of Alzheimer's disease

    ✓ Peer-reviewed Brain tissue and pathology Nature

    Key finding: Here we report a single-cell transcriptomic atlas of six different brain regions in the aged human brain, covering 1.3 million cells from 283 post-mortem human brain samples across 48 individuals with and without Alzheimer's disease. +3 more findings

  6. 2024-07-23

    Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Compared to non-Hispanic or Latino (NH) White participants, Hispanic or Latino (3.52 points, 95% confidence interval [CI]: [2.61, 4.42]); NH Asian (2.97 points, 95% CI: [1.71, 4.22]); and NH Black participants (2.79 points, 95% CI: [1.96, 3.63]) participants demonstrated higher levels of endorsement of the VPAI items at baseline. +4 more findings

  7. 2024-07-23

    Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research square

    Key finding: Using the SOMAscan assay, we detected subtle increases in specific ubiquitin enzymes associated with proteostasis in mutation carriers (MCs) up to two decades before the estimated symptom onset. +4 more findings

    Scored 22 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2024-07-23

    Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A strong linear relationship was observed between CTR values across brain regions. +4 more findings

  9. 2024-07-23

    Polygenic scores and Mendelian randomization identify plasma proteins causally implicated in Alzheimer's disease

    ✓ Peer-reviewed Genetics Frontiers in neuroscience

    Key finding: We identified four plasma protein level PGSs that were significantly associated (FDR-adjusted p < 0.05) with LOAD in a meta-analysis of the discovery and replication cohorts: CX3CL1, hepatocyte growth factor (HGF), TIE2, and matrix metalloproteinase-3 (MMP-3). +3 more findings

  10. 2024-07-23

    Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Concentration of CSF pT217/T217 had low predictive error (average error: 13%), but also a low predictive range (ceiling 63 Centiloids). +4 more findings

  11. 2024-07-23

    Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis

    ✓ Peer-reviewed Drug development Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

    Key finding: Newly conducted research suggests that metabolic disorders, like diabetes and obesity, play a significant role as risk factors for psychiatric disorders. +4 more findings

  12. 2024-07-22

    PM2.5 triggers tau aggregation in a mouse model of tauopathy

    ✓ Peer-reviewed Risk factors JCI insight

    Key finding: Epidemiological data show that exposure to fine particulate matter (PM2.5) is associated with an increased risk of AD. +3 more findings

  13. 2024-07-22

    18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes

    ✓ Peer-reviewed Brain scans and imaging Journal of neurology

    Key finding: 47 retired contact sport athletes negative for AD (age:51 ± 14; concussions/athlete:15 ± 2) and 54 normal controls (age:50 ± 13) were included. +4 more findings

  14. 2024-07-22

    Initial Perspectives From Rural-Residing Adults on a Digital Cognitive Health Coaching Intervention: Exploratory Qualitative Analysis

    ✓ Peer-reviewed Cognitive tests and assessment JMIR formative research

    Key finding: The following four themes emerged from participants' feedback: (1) healthy lifestyle and behavioral changes, (2) a sense of self-awareness through introspection, (3) value in coach support, and (4) a desire for a change in program format (eg, frequency). +4 more findings

  15. 2024-07-22
  16. 2024-07-20

    Multimerization of TREM2 is impaired by Alzheimer's disease-associated variants

    ✓ Peer-reviewed TREM2 and immune genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: TREM2 trimers remained stably bound, driven primarily by salt bridge between residues D87 and R76 at the interface of TREM2 units. +4 more findings

  17. 2024-07-19

    Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study

    ✓ Peer-reviewed Risk factors European journal of neurology

    Key finding: At baseline, 99 participants (10.1%) had covert brain infarcts and 91 (9.3%) had extensive periventricular white matter hyperintensities (WMHs). +4 more findings

  18. 2024-07-19

    Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration

    ✓ Peer-reviewed Drug development Biomolecules

    Key finding: In addition, our results indicate that these multi-agonists have the potential to outperform commercially available single GLP-1R agonists in neurodegenerative disease treatment.

  19. 2024-07-19

    Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: This study provides a systematic framework for selection of assay-specific cutpoints for clinical use of plasma p-tau217 for determination of amyloid status. +3 more findings

  20. 2024-07-19

    Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare

    ✓ Peer-reviewed Health systems and care delivery JAMA Health Forum

    Key finding: Receipt of potentially burdensome hospitalizations and treatments; receipt of postdischarge home and facility care. +4 more findings

  21. 2024-07-18

    Associations of sugar intake, high-sugar dietary pattern, and the risk of dementia: a prospective cohort study of 210,832 participants

    ✓ Peer-reviewed Prevention and risk BMC medicine

    Key finding: Increased absolute sugar intake (g/day) was significantly associated with a higher risk of all-cause dementia (HR = 1.003, [95%CI: 1.002-1.004], p < 0.001) and Alzheimer's disease (1.002, [1.001-1.004], 0.005). +4 more findings

  22. 2024-07-18

    Eye-brain connections revealed by multimodal retinal and brain imaging genetics

    ✓ Peer-reviewed Brain scans and imaging Nature communications

    Key finding: Overall, our findings reveal the genetic basis for eye-brain connections, suggesting that retinal images can help uncover genetic risk factors for brain disorders and disease-related changes in intracranial structure and function.

  23. 2024-07-18

    Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer's disease

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: In addition to the apolipoprotein E (APOE) locus, our GWAS of two independent Chinese samples uncovered three novel AD susceptibility loci (KIAA2013, SLC52A3, and TCN2) and a novel ancestry-specific variant within EGFR (rs1815157). +4 more findings

  24. 2024-07-18

    Exploring the effect of APOE ε4 on biomarkers of neurodegeneration in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Clinica chimica acta; international journal of clinical chemistry

    Key finding: The study population consisted of 194 patients (123 AD and 71 non-AD). +4 more findings

  25. 2024-07-18

    Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study

    ✓ Peer-reviewed Biomarkers The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: Our findings suggest AD-type tau is not higher in LLD compared to non-depressed, cognitively unimpaired older adults and appears unlikely to contribute to lower gray matter volume in LLD, further underscoring the need to distinguish major depressive disorder from depressive symptoms occurring in early AD. +4 more findings

Browse the library by subject, with the full score breakdown →